Abstract
BackgroundWe sought to determine if racial disparities in treatment and survival persist among patients with breast cancer in the Midsouth. MethodsPatients with early-stage breast cancer were identified in the tumor registry of a large healthcare system in the Midsouth. Regression analyses were performed to determine how race was associated with receipt of treatment and mortality. ResultsAmong 4605 patients, 38.8% were Black. Black patients were less likely to undergo surgery (OR = 0.71; 95%CI 0.53–0.97) and receive hormone therapy (OR = 0.81; 95%CI 0.69–0.95) than White patients, but more likely to receive radiation (OR = 1.20; 95%CI 1.08–1.40) and chemotherapy (OR = 1.36; 95%CI 1.16–1.61). Among Black patients, the risk of mortality was lower among those who underwent partial (OR = 0.25; 95%CI 0.12–0.51) or total (OR = 0.35; 95%CI 0.16–0.76) mastectomy and among those who received hormone therapy (OR = 0.62; 95%CI 0.40–0.97). ConclusionThere remains room for improvement in providing treatments that optimize survival among this patient population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
